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Abstract
Background: Depression and anxiety are common psychiatric symptoms in patients with epilepsy,
exerting a profound negative effect on health-related quality of life. Several issues, however,
pertaining to their association with psychosocial, seizure-related and medication factors, remain
controversial. Accordingly, the present study was designed to investigate the association of
interictal mood disorders with various demographic and seizure-related variables in patients with
newly-diagnosed and chronic epilepsy.
Methods: We investigated 201 patients with epilepsy (51.2% males, mean age 33.2 ± 10.0 years,
range 16–60) with a mean disease duration of 13.9 ± 9.5 years. Depression and anxiety were
assessed in the interictal state with the Beck Depression Inventory, 21-item version (BDI-21) and
the state and trait subscales of the State-Trait Anxiety Inventory (STAI-S and STAI-T), respectively.
The association of mood disorders with various variables was investigated with simple and multiple
linear regression analyses.
Results:  High seizure frequency and symptomatic focal epilepsy (SFE) were independent
determinants of depression, together accounting for 12.4% of the variation of the BDI-21. The
STAI-S index was significantly associated with the type of epilepsy syndrome (SFE). Finally, high
seizure frequency, SFE and female gender were independent determinants of trait anxiety
accounting for 14.7% of the variation of the STAI-T.
Conclusion: Our results confirm the prevailing view that depression and anxiety are common
psychological disorders in epileptics. It is additionally concluded that female gender, high seizure
frequency and a symptomatic epilepsy syndrome are independent risk factors for the development
of anxiety and/or depression.
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Background
Despite the fact that some patients with epilepsy lead nor-
mal lives, devoid of cognitive or emotional problems, a
significant number of them experience psychiatric distur-
bances, including mood disorders. Amongst the latter,
depression is the most extensively studied with a large
number of controlled studies reporting prevalence rates
ranging from 3–55% [1]. Anxiety might be even more
common, occurring in 25% of epileptic subjects in a com-
munity setting (versus 9% classified as depressed) [2]
whereas in secondary care and specialist centers its preva-
lence exceeds 50% [3,4]. Of particular clinical importance
is the recent finding that depression and anxiety exert a
profound negative effect on the health-related quality of
life (HRQOL) in patients with epilepsy. For instance, in a
study by Choi-Kwon et al [5], depression and anxiety
explained more variance in HRQOL than did any other
seizure-related or demographic variable.
While the impact of mood disorders on HRQOL in epi-
lepsy is now well established, several other issues pertain-
ing to their association with psychosocial, seizure-related
and medication factors, remain controversial. For
instance, gender [6-8] and seizure etiology [9-12] have
been variously reported as being significantly or non-sig-
nificantly associated with mood disorders, most likely due
to methodological differences amongst relevant studies.
The resolution of these controversies is not only of theo-
retical but also of practical importance, as a clear under-
standing of the complex pathogenesis of mood disorders
in epilepsy is a prerequisite for the development of effec-
tive intervention strategies.
Accordingly, the present study was designed to investigate
the association of interictal mood disorders with various
demographic and seizure-related variables in patients
with newly-diagnosed and chronic epilepsy.
Methods
Patients attending the Outpatient Epilepsy Clinics of three
University Hospitals entered this study after giving
informed consent for the procedures that were approved
by an institutional review board.
All participants were previously subjected to a thorough
clinical and laboratory investigation, including electroen-
cephalogram (EEG) and high-resolution brain magnetic
resonance imaging (MRI) scanning, so as to categorize
their epilepsy syndrome according to the 1989 ILAE clas-
sification [13]. This classification system utilizes two axes
(localization and etiology) in order to categorize epilepsy
syndromes. With regard to localization, epilepsies are
classified as focal (synonymous terms: partial- or localiza-
tion-related) and generalized. Regarding etiology, epilep-
sies are classified as idiopathic, symptomatic or
cryptogenic. The latter are defined as epileptic syndromes
that are believed to be symptomatic, but no etiology can
currently be identified.
Study inclusion criteria were as follows: (1) No clinical
seizure for at least 7 days prior to study entry. As most
cases of ictal and post-ictal anxiety and depression abate
within 2–3 days [14], the focus of the present study was
exclusively on interictal mood disorders. It should be
noted that the distinction between interictal (i.e. occur-
ring in the periods inbetween epileptic seizures) and ictal
and post-ictal mood disorders is a crucial one, because
they differ regarding the underlying pathophysiological
mechanisms. The former might represent psychological
worries about the occurrence of seizures and their possi-
ble consequences whereas the latter are directly related to
epileptic discharges. (2) No history of status epilepticus
for at least 6 months prior to study entry. (3) No history
of psychotropic medication intake including benzodi-
azepines. (4) No history of substance or alcohol abuse.
(5) A Mini-Mental State Examination (MMSE) > 24.
Thereby, all patients with significant cognitive dysfunc-
tion were excluded from the study. The treating neurolo-
gists made every possible effort to ensure that patients did
not experience any CNS side effects from their antiepilep-
tic medication at the time of psychological testing that
might interfere with the assessment.
All subjects were administered the following instruments:
(1) Beck Depression Inventory, 21 item version (BDI-21),
a widely used and well validated 21-item self-report
inventory of depressive symptoms [15]. The BDI-21 score
ranges from 0 to 63. (2) State-Trait Anxiety Inventory
(STAI), an extensively used self-administered inventory of
two sections containing 20 items each, designed to
explore anxiety in its state and trait dimensions [16]. The
minimum score for each section is 20, with a maximum
score of 80. (3) MMSE [17]. As previously noted, all
patients with a MMSE score < 24 were excluded from fur-
ther evaluation.
Statistical analysis
Continuous data are presented as mean ± standard devia-
tion (SD) while non-continuous variables are given as
percentages.
In order to assess which factors are independently associ-
ated with BDI-21, STAI-S and STAI-T, a two-step approach
was adopted. As a first step, simple regression analyses
were performed with various factors such as age, gender,
the type of epilepsy syndrome, number of antiepileptic
drugs and disease duration selected as independent varia-
bles while BDI-21 and STAI-S and -T were selected as
dependent variables. Subsequently, the most significant
of these factors were further investigated with multipleAnnals of General Psychiatry 2007, 6:28 http://www.annals-general-psychiatry.com/content/6/1/28
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regression analysis. Data concerning age, duration of dis-
ease, BDI-21 and STAI were entered in the model as con-
tinuous variables, while the variables of gender, epilepsy
type and medication were entered in the model as dum-
mies variables. Seizure frequency was abbreviated as SF
and the type of epileptic syndrome was denoted as CFE for
cryptogenic focal epilepsy, SFE for symptomatic focal epi-
lepsy and IGE for idiopathic generalized epilepsy, Medica-
tion was coded as AED1–3 indicating the use of 1–3
antiepileptic drugs, respectively.
The associations between dependent and independent
variables are presented by means of unstandardized linear
regression coefficients and 95% confidence intervals. In
addition, all reported associations were ranked according
to the absolute value of their standardized effect, which
was quantified by the standardized regression coefficients
(β). A standardized regression coefficient is defined as a
regression coefficient that has the effect of the measure-
ment scale removed so that the size of the coefficient can
be interpreted; it is calculated by multiplying the regres-
sion coefficient by the ratio of the standard deviation
(SDx) of the independent variable to the standard devia-
tion (SDy) of the dependent variable (β = regression coef-
ficient × SDx/SDy).
For all tests, p < 0.05 was the level of significance. Statisti-
cal analysis was performed using a commercially available
statistical package (SPSS for Windows version 13; SPSS,
Chicago, IL, USA).
Results
Table 1 presents the demographic data and principal char-
acteristics of our sample (n = 201). The age of the patients
ranged from 16–60 years with a mean value of 33.2 years.
The BDI-21 score had a mean value of 7.6 ± 7.3 with 32%
of the study population having scores ≥ of 15, which is the
cut-off point of the Greek version of the BDI-21 [18].
STAI-S and STAI-T had mean scores of 48.6 ± 6.7 and 42.9
± 6.7, respectively, and both were significantly increased
compared to control values obtained in healthy volun-
teers (24.95 ± 11.36 for the state and 27.88 ± 11.43 for the
trait score, p < 0.001).
Table 2 presents the estimated association levels of
depression quantified using the BDI-21 index, with
demographic and clinical characteristics that were evalu-
ated using simple linear regression analyses. Variables
such as seizure frequency, type of epilepsy syndrome and
number of antiepileptic drugs were significantly (p <
0.01) associated with BDI-21. More specifically, BDI-21
was positively associated with symptomatic focal epilepsy
(β = 3.60, p < 0.001) and negatively with idiopathic gen-
eralized epilepsy (β = -3.35, p = 0.007) (Figure 1). High
seizure frequency (SF > 1/month) and a high number of
antiepileptic drugs (AED3) were positively associated
with depression (β = 4.88, p < 0.001 and β = 3.065, p =
0.034, respectively) whereas a low number of antiepilep-
tic drugs (AED1) showed a negative association with the
depression index (β = -2.52, p = 0.014). Finally, female
gender showed a trend towards being significantly associ-
ated with the BDI-21 index (β = 1.99, p = 0.054).
To determine whether the association between seizure fre-
quency and BDI-21 index was independent of the type of
epilepsy syndrome (SFE), a backward multiple regression
analysis was performed. The results of the multiple regres-
sion analysis are presented in Table 3 and reveal that the
unstandardized coefficients of both SF > 1/month (β =
4.35, p = 0.001) and SFE (β = 3.05, p = 0.002) were inde-
pendent determinants of BDI-21. The predicted multiple
regression model accounted jointly for 12.4% of the vari-
ation of the BDI-21 (R2 = 0.124).
The associations of levels of anxiety quantified using STAI-
S with demographic and clinical characteristics is pre-
sented in Table 4. It is concluded that only the type of epi-
lepsy is significantly associated with the STAI-S index (p <
0.001). In particular, SFE was positively correlated to
STAI-S (β = 4.39, p < 0.001), whereas CFE showed a neg-
ative correlation (β = -3.675, p < 0.001). The results of
multiple regression analysis, however, showed that only
SFE was an independent determinant of STAI-S (β =
Table 1: Demographic data and principal characteristics of the study sample (n = 201)
Variable Mean ± SD/% Variable Mean ± SD/%
STAI-S 48.6 ± 6.7 Seizure frequency > 1/year 44.3%
STAI-T 42.9 ± 6.7 Cryptogenic focal epilepsy 27.4%
BDI-21 7.6 ± 7.3 Symptomatic focal epilepsy 51.2%
Age 33.2 ± 10.0 Idiopathic generalized epilepsy 21.4%
Disease duration 13.9 ± 9.5 Antiepileptic drug 1 50.2%
Male gender 51.2% Antiepileptic drug 2 34.8%
Seizure frequency > 1/month 23.9% Antiepileptic drug 3 14.9%
Seizure frequency < 1/year 31.8%
Non-continues variables are presented as percentages. Continuous variables are presented as Mean ± SD.Annals of General Psychiatry 2007, 6:28 http://www.annals-general-psychiatry.com/content/6/1/28
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4.391, 95% CI 2.625–6.156, p < 0.001). The predicted
multiple regression model accounted for 10.4% of the
variation of the STAI-S (R2 = 0.108).
The associations of levels of anxiety quantified using STAI-
T index with demographic and clinical characteristics are
presented in Table 5. Variables such as seizure frequency
> 1/month and > 1/year, as well as SFE, CFE and the
patient's gender were significantly associated with STAI-T
index (p < 0.001). In particular, high seizure frequency
(SF > 1/month (β = 3.85, p < 0.001)), polypharmacy
(AED3 (β = 3.242, p = 0.015), SFE (β = 3.52, p < 0.001)
(Figure 2) and female gender (β = 2.85, p = 0.002) were
positively correlated to the STAI-T. In contrast, low seizure
frequency (SF > 1/year, β = -2.761, p = 0.004), use of mon-
otherapy (AED1, β = -2.277, p = 0.016) and cryptogenic
focal epilepsy (CFE, β = -2.657, p = 0.012) were found to
be negatively correlated with the STAI-T index.
To determine whether the association between seizure fre-
quency and STAI-T, as well as between gender and STAI-T
were independent of the type of epilepsy, multiple regres-
sion analysis was employed. The estimated coefficients of
the multiple regression analysis are presented in Table 6
and reveal that only high seizure frequency (β = 3.56, p =
0.001), SFE (β = 2.61, p = 0.004) and female gender (β =
2.56, p = 0.005) were independent determinants of STAI-
T. The predicted multiple regression model account
jointly for 14.7% of the variation of the STAI-T (R2 =
0.147).
Discussion
The present cross-sectional study investigated the associa-
tion of certain demographic and seizure-related variables
with mood disorders in patients with epilepsy. Our results
confirm the prevailing view that depression and anxiety
are common psychological disorders in epileptics. It is
additionally concluded that female gender, high seizure
frequency and a symptomatic epilepsy syndrome are inde-
pendent, positively associated factors for the development
of anxiety and/or depression.
The effect of gender on the development of psychiatric
disturbances in epilepsy has been highly controversial in
previous studies, most likely due to diverse methodologi-
cal approaches and differences in the investigated popula-
tions. With regard to depression, Altshuler et al [7]
Scattergram demonstrating the relationship between BDI  score and the type of epilepsy syndrome Figure 1
Scattergram demonstrating the relationship 
between BDI score and the type of epilepsy syn-
drome. SFE: symptomatic focal epilepsy, CFE: cryptogenic 
focal epilepsy, IGE: idiopathic generalized epilepsy. A linear 
regression line and the 95% confidence band are shown. 
Slope: -2.299 ± 0.6290 (95% confidence interval: -3.532 to -
1.066); y-intercept: 11.50 ± 1.182 (95% CI: 9.187 to 13.82); p 
< 0.001.
Table 2: Simple linear regression analyses of factors associated with BDI-21
95% Confidence interval
Factor Unstandardized 
coefficient
Lower bound Upper bound Standardized 
coefficients
p Value R2
Gender 1.991 -0.036 4.018 0.136 0.054 0.018
Seizure frequency > 1/month 4.888 2.588 7.187 0.285 < 0.001 0.081
Seizure frequency < 1/year -2.129 -4.305 0.046 -0.136 0.055 0.018
Seizure frequency > 1/year -1.728 -3.773 0.317 -0.117 0.097 0.014
Symptomatic focal epilepsy 3.605 1.621 5.588 0.246 < 0.001 0.061
Cryptogenic Focal Epilepsy -1.691 -3.973 0.591 -0.103 0.145 0.103
Idiopathic generalized epilepsy -3.357 -5.806 -0.907 -0.188 0.007 0.035
Antiepileptic drug 1 -2.523 -4.538 -0.508 -0.172 0.014 0.030
Antiepileptic drug 1 1.064 -1.077 3.206 0.069 0.328 0.005
Antiepileptic drug 1 3.065 0.227 5.904 0.149 0.034 0.022
Age -0.040 -0.142 0.062 -0.054 0.443 0.003
Duration of disease -0.036 -0.145 0.073 -0.046 0.516 0.002Annals of General Psychiatry 2007, 6:28 http://www.annals-general-psychiatry.com/content/6/1/28
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observed that male patients with temporal lobe epilepsy
had the highest scores on the BDI-21, and Strauss et al [6]
observed that men with left-sided temporal foci were
more vulnerable to depression. Other investigators have
also concluded that men are overrepresented in depressed
patients [12,19,20] and in groups of patients with self-
destructive tendencies [21]. By contrast, a number of stud-
ies reported opposite results with gender having either no
effect [22,23] or with a preponderance (though not statis-
tically significant) of female patients with epilepsy and
depression [8]. Our results are in line with this latter
study, showing a trend towards significant association
between female gender and depression in epilepsy. The
lack of a clear-cut gender difference in the prevalence of
depression among epilepsy patients is worth noting in
view of the fact that female gender is a recognized risk fac-
tor for depression in non-epileptic populations [1].
With regard to anxiety in epilepsy, gender is generally con-
sidered to have a subtle effect [24] with the notable excep-
tion of the study by Jacoby et al [2], which concluded that
female patients tend to be more anxious than men. Our
results reveal an interesting novel finding, namely that the
effect of gender critically depends on the specific aspects
of anxiety investigated. In the present study we adminis-
tered STAI [16], which is a self-completed questionnaire
consisting of two different 20-item forms. The former
(STAI-S) measures various subjective and somatic mani-
festations of anxiety at a given moment. In contrast, the
latter (STAI-T) refers to relatively stable individual differ-
ences in anxiety proneness as a personality trait [25]. Our
results indicate that female patients had significantly
higher scores on STAI-T compared to males. This finding
is reminiscent of the pattern occurring in normal subjects
as trait scores have been previously reported to be more
common in women [26]. Therefore, it most likely reflects
a tendency observed in the general population. In con-
trast, no gender difference was disclosed regarding STAI-S,
and therefore interictal anxiety in its state form is not
related to gender. Previous studies have attributed interic-
tal anxiety to a combination of biological factors (i.e. sei-
zure-induced alterations of neuronal circuits in the
amygdala region via a kindling-like mechanism) [27] and
psychological worries concerning, for instance, the possi-
bility of seizure-related injuries or the impact of epilepsy
on employment and marital status [28,29].
Seizure frequency has been linked to psychological distur-
bances in a number of relevant studies. With regard to
depression, Boylan et al [30] reported that 50% of inpa-
Table 4: Simple linear regression analyses of factors associated with STAI-S
95% Confidence interval
Factor Unstandardized 
coefficient
Lower Bound Upper Bound Standardized 
coefficients
p Value R2
Gender 1.603 -0.253 3.458 0.120 0.090 0.009
Seizure frequency > 1/month 1.186 -0.999 3.371 0.076 0.286 0.006
Seizure frequency < 1/year 1.073 -0.927 3.073 0.075 0.291 0.006
Seizure frequency > 1/year -1.818 -3.681 0.046 -0.135 0.056 0.018
Symptomatic focal epilepsy 4.391 2.625 6.156 0.328 < 0.001 0.108
Cryptogenic focal epilepsy -3.675 -5.707 -1.644 -0.245 < 0.001 0.060
Idiopathic generalized epilepsy -2.180 -4.437 0.078 -0.134 0.058 0.018
Antiepileptic drug 1 -1.618 -3.473 0.237 -0.121 0.087 0.015
Antiepileptic drug 2 1.122 -0.832 3.077 0.080 0.259 0.006
Antiepileptic drug 3 1.179 -1.438 3.796 0.063 0.375 0.004
Age 0.001 -0.093 0.094 0.001 0.988 0
Duration of disease 0.096 -0.002 0.194 0.136 0.055 0.019
Table 3: Multiple linear regression of factors associated with BDI-21
95% Confidence interval
Factor Unstandardized 
coefficient
Lower bound Upper bound Standardized 
coefficients
p Value Tolerance
(Constant) 4.990 3.559 6.420 0.001
Seizure frequency > 1/month 4.353 2.076 6.630 0.254 0.001 0.978
Symptomatic focal epilepsy 3.050 1.107 4.402 0.208 0.002 0.978
The base omitted factors are gender, SF < 1/year, SF > 1/year, CFE, IGE, AED1, AED2, AED 3, age and disease duration.Annals of General Psychiatry 2007, 6:28 http://www.annals-general-psychiatry.com/content/6/1/28
Page 6 of 8
(page number not for citation purposes)
tients undergoing video-EEG telemetry suffered from
depression with 19% exhibiting suicidal ideation. Jacoby
et al [2] observed in a community-based survey that 21%
of patients with recurrent seizures were depressed versus
9% of controlled subjects and O'Donoghue et al [31] have
similarly demonstrated at primary care level that 33% of
patients with recurrent seizures versus 6% of those in
remission had probable depression. Overall, the preva-
lence of depression has been reported to range from 20 to
55% in pharmacoresistant populations versus 3–9% in
well controlled subjects [32]. Parenthetically, the occur-
rence of depression in epileptic patients, particularly those
with high seizure counts, might seem paradoxical as one
of the most powerful treatments for depression is electro-
convulsive therapy, which is entirely based on the tenet of
the antidepressive effects of convulsions.
Regarding anxiety, Smith et al [33] classified 33% of drug-
resistant epileptics recruited from a referral center as clin-
ically anxious with a group mean score of 7.7 in the Ham-
ilton Anxiety and Depression scale. In contrast, Jacoby et
al [2] reported that 25% of patients in a large community-
based study suffered from anxiety with a group mean of
6.8 on the HAD scale and ascribed the lower prevalence
figures of anxiety in their study to the fact a large percent-
age of patients were either seizure-free or experiencing
infrequent seizures. Our results are in line with the above-
mentioned views indicating a positive association
between high seizure frequency and increased scoring on
the BDI-21, STAI-S and STAI-T scales. It should be noted
that this association is not a direct one as ictal and post-
ictal anxiety and depression have been a priori excluded by
the design of the present study. It rather indicates that as
the burden of epilepsy increases, so does the severity of
mood disorders.
The important issue of the relationship between specific
epilepsy syndromes and the development of mood disor-
ders has not been thoroughly addressed in the past, as
most of the relevant studies have analyzed seizure sub-
types and etiology as separate factors while very few have
utilized a syndromic approach. Our data suggest that cryp-
togenic or symptomatic focal epilepsies are positively
associated with the presence of psychological distur-
bances. This finding was anticipated, to some degree, in
view of the results of previous studies. Partial seizures are
a hallmark of focal epilepsies, and a number of investiga-
Scattergram demonstrating the relationship between STAI-2  score and the type of epilepsy syndrome Figure 2
Scattergram demonstrating the relationship 
between STAI-2 score and the type of epilepsy syn-
drome. SFE: symptomatic focal epilepsy, CFE: cryptogenic 
focal epilepsy, IGE: idiopathic generalized epilepsy. A linear 
regression line and the 95% confidence band are shown. 
Slope: -1.932 ± 0.5797 (95% confidence interval: -3.068 to -
0.7957); y-intercept: 46.16 ± 1.090 (95% CI: 44.03 to 48.30); 
p < 0.001.
Table 5: Simple linear regression analyses of factors associated with STAI-T
95% Confidence interval
Factor Unstandardized 
coefficient
Lower bound Upper bound Standardized 
coefficients
p Value R2
Gender 2.851 1.018 4.684 0.212 0.002 0.045
Seizure frequency > 1/month 3.858 1.726 5.990 0.245 < 0.001 0.060
Seizure frequency < 1/year -0.093 -2.105 1.920 -0.006 0.928 0
Seizure frequency > 1/year -2.761 -4.609 -0.913 -0.204 0.004 0.042
Symptomatic focal epilepsy 3.521 1.711 5.331 0.262 < 0.001 0.069
Cryptogenic focal epilepsy -2.657 -4.727 -0.587 -0.177 0.012 0.031
Idiopathic generalized epilepsy -2.090 -4.358 0.178 -0.128 0.071 0.016
Antiepileptic drug 1 -2.277 -4.126 -0.429 -0.170 0.016 0.029
Antiepileptic drug 2 0.695 -1.271 2.661 0.049 0.487 0.002
Antiepileptic drug 3 3.242 0.649 5.834 0.172 0.015 0.030
Age -0.032 -0.126 0.062 -0.048 0.499 0.002
Duration of disease 0.047 -0.053 0.147 0.066 0.356 0.004Annals of General Psychiatry 2007, 6:28 http://www.annals-general-psychiatry.com/content/6/1/28
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tions have clearly established that partial seizures, partic-
ularly complex partial seizures of temporal lobe origin,
are a risk factor for the development of depression and
anxiety [6,12,34-37].
The effect of seizure etiology, however, has been rather
inconsistent. For instance, some [9,10], but not all
[11,12], relevant studies have reported that depression is
more common in epileptic patients with a structural
lesion. Our finding that symptomatic epilepsies are asso-
ciated with increased anxiety and depression is certainly
in line with the former ones. This view is intuitively cor-
rect, as depression is commonly associated with neurolog-
ical conditions (i.e. stroke or head injury) that are also
responsible for epilepsy.
In conclusion, our results confirm the generally held view
that mood disorders are common in patients with newly
diagnosed and chronic epilepsy and provide further
insight to the association of depression and anxiety with
certain demographic and seizure-related variables.
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